ACADIA Pharmaceuticals
ACAD
#3901
Rank
NZ$4.09 B
Marketcap
$24.67
Share price
-0.78%
Change (1 day)
-31.13%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2024 (TTM): NZ$72.04 M

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings (TTM) are NZ$73.93 M. In 2023 the company made an earning of -NZ$82.5 M an increase over its 2022 earnings that were of -NZ$0.35 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$72.04 M-187.33%
2023 -NZ$82.5 M-76.09%
2022 -NZ$0.35 B27.41%
2021 -NZ$0.28 B-40.38%
2020 -NZ$0.46 B19.88%
2019 -NZ$0.38 B-3.92%
2018 -NZ$0.4 B-15.04%
2017 -NZ$0.47 B6.33%
2016 -NZ$0.44 B64.55%
2015 -NZ$0.27 B77.47%
2014 -NZ$0.15 B143.69%
2013 -NZ$61.34 M81.93%
2012 -NZ$33.72 M-8.73%
2011 -NZ$36.94 M-251.39%
2010 NZ$24.39 M-133.2%
2009 -NZ$73.5 M-30.82%
2008 -NZ$0.11 B6.43%
2007 -NZ$99.82 M25.89%
2006 -NZ$79.29 M36.99%
2005 -NZ$57.88 M37.22%
2004 -NZ$42.18 M19.96%
2003 -NZ$35.17 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$52.49 M-170.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$1.96 B-2,749.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$14.53 B 19,551.32%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$32.76 B 44,218.38%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$10.38 B-14,132.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$62.44 M-184.45%๐Ÿ‡บ๐Ÿ‡ธ USA